Pfizer Inc (PFE)

$25.96 +0.09 (0.35%)
Market Cap 147.10B
Revenue (ttm) 62.58B
Net Income (ttm) 7.77B
EPS (ttm) N/A
PE Ratio 8.39
Forward PE 8.62
Profit Margin 12.42%
Debt to Equity Ratio 0.71
Volume 39,408,395
Avg Vol 38,374,336
Day's Range N/A - N/A
Shares Out 5.70B
Stochastic %K 21%
Beta 0.35
Analysts Sell
Price Target $29.20

Company Profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands;...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 212 733 2323
Address:
66 Hudson Boulevard East, New York, United States
FrankieSmilez
FrankieSmilez May. 13 at 11:35 PM
$SPY $MRNA $PFE $QQQ Probably nothing, right?
2 · Reply
Skyhigh_69
Skyhigh_69 May. 13 at 11:01 PM
$PFE Once it takes 26.60, monthly bias turns bullish. Will be a huge sign. Lets see if can turn green on the monthly in next few days.
0 · Reply
Skyhigh_69
Skyhigh_69 May. 13 at 10:37 PM
$PFE I hate this turd. Which is usually a great sign. Hold the line just a little bit now. I know if I sell it will go to 30. So I'm just gonna hold the line. I think downside manipulation was completed by the MM under 25.90. Can only go up now. Chart is identical right before it went up 15% in 2 days last year.
0 · Reply
Skyhigh_69
Skyhigh_69 May. 13 at 10:31 PM
$PFE some's gotta give. Inflection point - ✔️ Bear trap - ✔️ Bulls disillusioned- ✔️ This can only mean 1 thing. We 🚀 (hopefully up)
0 · Reply
WuTangClam
WuTangClam May. 13 at 10:29 PM
$SPY This is why you NEED a long term. Separate your trading account with your long term account. I don't care your political views. If u want to stay in the game U NEED A LONG TERM) The rule of thumb is 80% of your invested money into long term quality stocks that you will hold for 10 years, and 20% into options/day trades( if you know how to trade correctly ) don't gamble , invest. I've been doing this for over 15 years and blew many accounts. But I always had my long term investments backing me up. Separate your long term and trading account use different brokers. High quality is very important. Get the long term down you will get the trading down $QQQ $AMD $PFE $GOOGL
4 · Reply
OG80
OG80 May. 13 at 9:38 PM
$PFE 26.50 too much to ask?
4 · Reply
BonprixUltimateGuardians
BonprixUltimateGuardians May. 13 at 9:06 PM
$PFE $OSCR $SIDU $FLY $ETN replay
0 · Reply
pasuny
pasuny May. 13 at 8:48 PM
$PFE Stupid dirty filthy garbage selling toxic chemicals to innocent people. Disgusting.
1 · Reply
Skyhigh_69
Skyhigh_69 May. 13 at 8:09 PM
$PFE Let the Pfun begin. Looking for a 10% week soon. Maybe 15%.
1 · Reply
MrPeanutEsquire
MrPeanutEsquire May. 13 at 8:04 PM
$PFE 8 CENTS!? thats 400% better than my expectation of 2 cents! Hell yeah
3 · Reply
Latest News on PFE
Mixed options sentiment in Pfizer with shares up 0.48%

2026-05-13T19:23:39.000Z - 4 hours ago

Mixed options sentiment in Pfizer with shares up 0.48%

Arvinas price target raised to $16 from $14 at BofA

2026-05-13T19:22:15.000Z - 4 hours ago

Arvinas price target raised to $16 from $14 at BofA

ARVN RIGL

Pfizer says EC grants marketing approval to expand indication for Hympavzi

2026-05-13T11:10:14.000Z - 12 hours ago

Pfizer says EC grants marketing approval to expand indication for Hympavzi

European Commission Approves Pfizer's HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors

May 13, 2026, 6:45 AM EDT - 13 hours ago

European Commission Approves Pfizer's HYMPAVZI for the Treatment of Adults and Adolescents with Hemophilia A or B With Inhibitors

Pfizer (PFE) Delivered a Solid Q1. The Patent Cliff Keeps Me Bearish

2026-05-13T07:12:25.000Z - 16 hours ago

Pfizer (PFE) Delivered a Solid Q1. The Patent Cliff Keeps Me Bearish

LLY NVO

H.C. Wainwright says Pfizer handing off Veppanu to Rigel ‘makes strategic sense’

2026-05-12T17:45:03.000Z - 1 day ago

H.C. Wainwright says Pfizer handing off Veppanu to Rigel ‘makes strategic sense’

ARVN RIGL

Arvinas, Pfizer enter license pact with Rigel Pharmaceuticals for Veppanu

2026-05-12T16:35:26.000Z - 1 day ago

Arvinas, Pfizer enter license pact with Rigel Pharmaceuticals for Veppanu

ARVN RIGL

Rigel Pharmaceuticals enters license agreement with Arvinas, Pfizer

2026-05-12T13:02:04.000Z - 1 day ago

Rigel Pharmaceuticals enters license agreement with Arvinas, Pfizer

ARVN RIGL

Rigel strikes licensing deal for Pfizer and Arvinas' breast cancer drug

May 12, 2026, 8:00 AM EDT - 1 day ago

Rigel strikes licensing deal for Pfizer and Arvinas' breast cancer drug

ARVN RIGL

Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)

May 12, 2026, 7:00 AM EDT - 1 day ago

Arvinas and Pfizer Enter into a Transaction with Rigel Pharmaceuticals for the Exclusive Global Rights of VEPPANU (vepdegestrant)

ARVN

Mixed options sentiment in Pfizer with shares down 1.52%

2026-05-08T22:49:53.000Z - 5 days ago

Mixed options sentiment in Pfizer with shares down 1.52%

Mixed options sentiment in Pfizer with shares up 0.28%

2026-05-07T01:58:20.000Z - 6 days ago

Mixed options sentiment in Pfizer with shares up 0.28%

Pfizer sees high-single-digit annual revenue increases 2029-2033, WSJ reports

2026-05-05T20:09:06.000Z - 8 days ago

Pfizer sees high-single-digit annual revenue increases 2029-2033, WSJ reports

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

May 5, 2026, 4:09 PM EDT - 8 days ago

Pfizer CEO on Drug Pipeline, Trump's Pick to Lead CDC

Pfizer CEO on AI-designed molecule, and race to use new tech

May 5, 2026, 4:02 PM EDT - 8 days ago

Pfizer CEO on AI-designed molecule, and race to use new tech

BioNTech to cut up to 1,860 jobs, close multiple global sites, Reuters reports

2026-05-05T15:41:20.000Z - 8 days ago

BioNTech to cut up to 1,860 jobs, close multiple global sites, Reuters reports

BNTX

3 Dividend Stocks for May 2026

May 5, 2026, 11:30 AM EDT - 8 days ago

3 Dividend Stocks for May 2026

SYY WSO

Pfizer Earnings Call Transcript: Q1 2026

May 5, 2026, 10:00 AM EDT - 8 days ago

Pfizer Earnings Call Transcript: Q1 2026

Pfizer Posts Better-Than-Expected Revenue, Profit

May 5, 2026, 8:35 AM EDT - 8 days ago

Pfizer Posts Better-Than-Expected Revenue, Profit

Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending

May 5, 2026, 7:23 AM EDT - 8 days ago

Pfizer Revenue Rises But Profit Falls Amid Boosted R&D Spending

Pfizer Stock Edges Higher as Earnings and Revenue Beat Estimates

May 5, 2026, 7:06 AM EDT - 8 days ago

Pfizer Stock Edges Higher as Earnings and Revenue Beat Estimates

Why selling these 3 dividend stocks could be a mistake

May 5, 2026, 7:05 AM EDT - 8 days ago

Why selling these 3 dividend stocks could be a mistake

EPD UPS

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

May 5, 2026, 6:55 AM EDT - 8 days ago

Pfizer tops Wall Street estimates, reaffirms outlook as newer products show growth

Pfizer beats first-quarter profit estimates on strong demand for blood thinner Eliquis

May 5, 2026, 6:51 AM EDT - 8 days ago

Pfizer beats first-quarter profit estimates on strong demand for blood thinner Eliquis

Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance

May 5, 2026, 6:45 AM EDT - 8 days ago

Pfizer Reports Strong First-Quarter Results And Reaffirms 2026 Guidance

US FDA approves Pfizer, Arvinas' breast cancer drug

May 1, 2026, 12:37 PM EDT - 12 days ago

US FDA approves Pfizer, Arvinas' breast cancer drug

ARVN

Pfizer's blood cancer drug meets main goal in late-stage trial

Apr 29, 2026, 7:42 AM EDT - 14 days ago

Pfizer's blood cancer drug meets main goal in late-stage trial

Pfizer's ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma

Apr 29, 2026, 6:45 AM EDT - 14 days ago

Pfizer's ELREXFIO Significantly Improves Progression-Free Survival for Double-Class Exposed Patients with Relapsed or Refractory Multiple Myeloma

Pfizer secures deals to keep heart drug free of generic rivals until 2031

Apr 28, 2026, 10:41 AM EDT - 15 days ago

Pfizer secures deals to keep heart drug free of generic rivals until 2031

Pfizer Reaches Three Settlement Agreements for VYNDAMAX

Apr 28, 2026, 10:17 AM EDT - 15 days ago

Pfizer Reaches Three Settlement Agreements for VYNDAMAX

Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacy

Apr 24, 2026, 8:36 AM EDT - 19 days ago

Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacy

BMY

Pfizer Transcript: AGM 2026

Apr 23, 2026, 9:00 AM EDT - 20 days ago

Pfizer Transcript: AGM 2026

Pfizer Declares Second-Quarter 2026 Dividend

Apr 22, 2026, 4:45 PM EDT - 21 days ago

Pfizer Declares Second-Quarter 2026 Dividend

Pfizer GLP-1 weight loss drug available for pre-order in China

Apr 22, 2026, 5:18 AM EDT - 21 days ago

Pfizer GLP-1 weight loss drug available for pre-order in China

Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026

Apr 21, 2026, 11:51 AM EDT - 22 days ago

Pfizer Showcases Oncology Innovation and Next-Generation Pipeline at ASCO 2026

Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says

Apr 20, 2026, 3:05 PM EDT - 23 days ago

Pfizer's Strategy and Innovation Officer Andrew Baum to leave drugmaker, analyst note says

U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

Apr 20, 2026, 6:45 AM EDT - 23 days ago

U.S. FDA Grants Priority Review to sBLA for PADCEV™ + Keytruda® as Perioperative Treatment for Muscle-Invasive Bladder Cancer Regardless of Cisplatin Eligibility

The Big 3: PFE, V, SYF

Apr 16, 2026, 1:01 PM EDT - 27 days ago

The Big 3: PFE, V, SYF

SYF V

Big Pharma Is Turning to China for the Newest Drug Ideas

Apr 10, 2026, 11:00 PM EDT - 4 weeks ago

Big Pharma Is Turning to China for the Newest Drug Ideas

Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders

Apr 9, 2026, 10:00 AM EDT - 4 weeks ago

Pfizer Invites Shareholders to View and Listen to Webcast of April 23 Virtual 2026 Annual Meeting of Shareholders

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

Apr 2, 2026, 11:14 AM EDT - 5 weeks ago

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

NVO LLY

Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

Apr 1, 2026, 11:39 AM EDT - 6 weeks ago

Exclusive: Pfizer, BioNTech halt US COVID vaccine study after recruitment struggles

BNTX

Belgian court orders Poland, Romania to buy $2.2 billion of Pfizer COVID vaccines

Apr 1, 2026, 10:13 AM EDT - 6 weeks ago

Belgian court orders Poland, Romania to buy $2.2 billion of Pfizer COVID vaccines

Pharma Offers Defensive Plays in an Uncertain Market. Charts Say Buy These 2 Stocks.

Mar 30, 2026, 10:44 AM EDT - 6 weeks ago

Pharma Offers Defensive Plays in an Uncertain Market. Charts Say Buy These 2 Stocks.

GSK LLY NVO PPH

Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

Mar 24, 2026, 10:00 AM EDT - 7 weeks ago

Pfizer Invites Public to View and Listen to Webcast of May 5 Conference Call with Analysts

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive

Mar 23, 2026, 12:46 PM EDT - 7 weeks ago

An experimental Lyme disease vaccine from Pfizer and Valneva was effective at preventing the tick-borne disease in a new clinical trial but the findings aren't conclusive

VALN

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

Mar 23, 2026, 9:36 AM EDT - 7 weeks ago

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss

VALN

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

Mar 23, 2026, 7:07 AM EDT - 7 weeks ago

Pfizer and French partner to seek approval for Lyme disease vaccine after late-stage trial

VALN

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial

Mar 23, 2026, 7:02 AM EDT - 7 weeks ago

Pfizer, Valneva Report Strong Efficacy Data From Lyme Vaccine Trial

VALN

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

Mar 23, 2026, 6:47 AM EDT - 7 weeks ago

Pfizer-Valneva Lyme disease shot shows more than 70% efficacy in late-stage trial

VALN

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

Mar 23, 2026, 6:45 AM EDT - 7 weeks ago

Pfizer and Valneva Announce Lyme Disease Vaccine Candidate Demonstrates Strong Efficacy in Phase 3 VALOR Trial

VALN

5 ‘Healthy' Dividends Paying Up To 14.1%

Mar 22, 2026, 9:45 AM EDT - 7 weeks ago

5 ‘Healthy' Dividends Paying Up To 14.1%

ARE BME DOC HQH

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

Mar 20, 2026, 4:30 PM EDT - 7 weeks ago

Pfizer Recommends Shareholders Reject the Mini-Tender Offer by Tutanota LLC

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

Mar 19, 2026, 6:45 AM EDT - 7 weeks ago

TALZENNA Plus XTANDI Significantly Improves Radiographic Progression-Free Survival in Metastatic Prostate Cancer

TrumpRx lists many medicines at prices higher than paid in UK

Mar 18, 2026, 2:23 PM EDT - 2 months ago

TrumpRx lists many medicines at prices higher than paid in UK

ABBV AMGN AZN BMY GILD GSK JNJ

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

Mar 17, 2026, 7:49 AM EDT - 2 months ago

Pfizer says experimental breast cancer drug cuts risk of disease worsening in mid-stage trial

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Mar 17, 2026, 6:45 AM EDT - 2 months ago

Pfizer Announces Positive Topline Phase 2 Results for Next-Generation CDK4 Inhibitor, Atirmociclib, in Second-Line Metastatic Breast Cancer

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Mar 9, 2026, 7:27 AM EDT - 2 months ago

Pfizer's eczema drug meets main goal in mid-stage trial, plans late-stage study

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

Mar 9, 2026, 6:45 AM EDT - 2 months ago

Pfizer's Phase 2 Study of Trispecific Antibody Positive in Moderate to Severe Atopic Dermatitis

China approves Pfizer GLP-1 drug for weight management

Mar 6, 2026, 12:40 AM EST - 2 months ago

China approves Pfizer GLP-1 drug for weight management

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

Mar 5, 2026, 4:48 PM EST - 2 months ago

Judge approves Pfizer, SEC settlement tied to insider trading at Cohen hedge fund

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

Mar 4, 2026, 8:55 AM EST - 2 months ago

NYSE Content Update: Alysa Liu Rings NYSE Bell After Winning Two Gold Medals

SMWB

Pfizer CEO flags issues with FDA's vaccine leadership

Mar 2, 2026, 11:14 AM EST - 2 months ago

Pfizer CEO flags issues with FDA's vaccine leadership

FrankieSmilez
FrankieSmilez May. 13 at 11:35 PM
$SPY $MRNA $PFE $QQQ Probably nothing, right?
2 · Reply
Skyhigh_69
Skyhigh_69 May. 13 at 11:01 PM
$PFE Once it takes 26.60, monthly bias turns bullish. Will be a huge sign. Lets see if can turn green on the monthly in next few days.
0 · Reply
Skyhigh_69
Skyhigh_69 May. 13 at 10:37 PM
$PFE I hate this turd. Which is usually a great sign. Hold the line just a little bit now. I know if I sell it will go to 30. So I'm just gonna hold the line. I think downside manipulation was completed by the MM under 25.90. Can only go up now. Chart is identical right before it went up 15% in 2 days last year.
0 · Reply
Skyhigh_69
Skyhigh_69 May. 13 at 10:31 PM
$PFE some's gotta give. Inflection point - ✔️ Bear trap - ✔️ Bulls disillusioned- ✔️ This can only mean 1 thing. We 🚀 (hopefully up)
0 · Reply
WuTangClam
WuTangClam May. 13 at 10:29 PM
$SPY This is why you NEED a long term. Separate your trading account with your long term account. I don't care your political views. If u want to stay in the game U NEED A LONG TERM) The rule of thumb is 80% of your invested money into long term quality stocks that you will hold for 10 years, and 20% into options/day trades( if you know how to trade correctly ) don't gamble , invest. I've been doing this for over 15 years and blew many accounts. But I always had my long term investments backing me up. Separate your long term and trading account use different brokers. High quality is very important. Get the long term down you will get the trading down $QQQ $AMD $PFE $GOOGL
4 · Reply
OG80
OG80 May. 13 at 9:38 PM
$PFE 26.50 too much to ask?
4 · Reply
BonprixUltimateGuardians
BonprixUltimateGuardians May. 13 at 9:06 PM
$PFE $OSCR $SIDU $FLY $ETN replay
0 · Reply
pasuny
pasuny May. 13 at 8:48 PM
$PFE Stupid dirty filthy garbage selling toxic chemicals to innocent people. Disgusting.
1 · Reply
Skyhigh_69
Skyhigh_69 May. 13 at 8:09 PM
$PFE Let the Pfun begin. Looking for a 10% week soon. Maybe 15%.
1 · Reply
MrPeanutEsquire
MrPeanutEsquire May. 13 at 8:04 PM
$PFE 8 CENTS!? thats 400% better than my expectation of 2 cents! Hell yeah
3 · Reply
Skyhigh_69
Skyhigh_69 May. 13 at 8:04 PM
$PFE 6M volume in 2mins of market close. Obviosuly they're not selling more at these levels. Chart look eerily similar to 9/29/2025, before it moved 15% in two days.
1 · Reply
Itsokman
Itsokman May. 13 at 8:03 PM
$PFE That was thrilling!!!
1 · Reply
MrPeanutEsquire
MrPeanutEsquire May. 13 at 7:43 PM
$PFE Red or Green, my heart is racing! It could close either way and there is upwards of 2 cents on the line! The anticipation is killing me
0 · Reply
Micheal_Pothead
Micheal_Pothead May. 13 at 7:33 PM
$PFE gotta close it red
1 · Reply
Skyhigh_69
Skyhigh_69 May. 13 at 7:22 PM
$PFE Really feel this is the bottom here. I doubt it. I hope not though
2 · Reply
Micheal_Pothead
Micheal_Pothead May. 13 at 6:11 PM
$PFE LLY is up 20% of a Pfizer today
1 · Reply
BrandonHardesty
BrandonHardesty May. 13 at 5:43 PM
$PFE I love going into work everyday at Pfizer. At least, we have premium beef jerky and fruit cups at our meetings that could be emails.
2 · Reply
BrandonHardesty
BrandonHardesty May. 13 at 5:37 PM
$PFE
1 · Reply
MrPeanutEsquire
MrPeanutEsquire May. 13 at 5:12 PM
$PFE Lilly up yet another 1/6 of our market cap today
1 · Reply
JBS_84
JBS_84 May. 13 at 4:55 PM
$PFE tech bubble taking all the air out of the room... Still
1 · Reply
pasuny
pasuny May. 13 at 4:15 PM
$PFE God only knows what kind of very dirty and filthy scam operation they're running.
0 · Reply